CD274 and hepatocellular carcinoma: For example, in patients with advanced HCC (Hepatocellular Carcinoma), the predictive value of PD-L1 expression on tumor cells did not directly correlate with the patient response to anti-PD1 therapy according to the data from CheckMate 040 clinical trial (14).